Target intelligence / Profile preview

16S ribosomal RNA aminoacyl-tRNA site (16S rRNA A-site) (16S rRNA A-site)

Target
16S rRNA A-site
Molecular classification
Ribosomal RNA, Ribonucleoprotein, Bacterial ribosome component
01

Overview

The 16S ribosomal RNA (rRNA) A-site is a critical functional region within the 30S subunit of the bacterial ribosome, responsible for the decoding of genetic information during protein synthesis [1, 8]. It serves as the binding site for aminoacyl-tRNA molecules, where the fidelity of translation is ensured through precise codon-anticodon recognition [10, 15]. This site is the primary target for several classes of potent antibiotics, most notably aminoglycosides and tetracyclines [7, 17]. Aminoglycosides bind to the A-site and induce a conformational change that causes the ribosome to misread mRNA, leading to the production of erroneous, toxic proteins and eventual bacterial cell death [1, 20]. Tetracyclines, on the other hand, physically block the entry of tRNAs into the A-site, thereby halting protein elongation [15, 17]. Resistance to drugs targeting this site often arises through enzymatic modification of the antibiotics or post-transcriptional methylation of the 16S rRNA by methyltransferases, which prevents drug binding [4, 6].

Other names
Decoding site30S A-site16S rRNA decoding regionAminoacyl-tRNA binding site
02

Mechanism of action

Aminoglycosides bind to the A-site of the 16S rRNA, inducing a conformational change in residues A1492 and A1493 that mimics cognate tRNA binding, leading to mRNA misreading and inhibition of translocation [1, 3, 20]. Tetracyclines bind to the 30S subunit and sterically block the binding of aminoacyl-tRNA to the A-site [7, 17].

03

Biological functions

Protein synthesisTranslationDecodingTranslation fidelityTranslocation
04

Disease associations

Infection
05

Safety considerations

Ototoxicity [1, 11]Nephrotoxicity [1, 19]Neuromuscular blockade [11]Vestibulotoxicity [11]
06

Interacting drugs

Gentamicin

14 more in the full profile.

07

Biomarkers

16S rRNA methyltransferases (e.g., ArmA, RmtA-H, NpmA) [4, 6]16S rRNA A1408G mutation [4]Mitochondrial 12S rRNA m.1555A>G mutation [20]

Beyond the preview

Go deeper on 16S ribosomal RNA aminoacyl-tRNA site (16S rRNA A-site) (16S rRNA A-site).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 16S ribosomal RNA aminoacyl-tRNA site (16S rRNA A-site) (16S rRNA A-site).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call